Prevalence and risk factors of retinopathy of prematurity

Acta Academiae Medicinae Sinicae

Volumn 28, Issue 4, 2006, Pages 567-569

  Huo, Dong Mei ^a   Dong, Fang Tian ^a   Dai, Rong Ping ^a   Chu, Jie ^a   Yu, Wei Hong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Premature infant; Retinopathy; Risk factor

Indexed keywords

DEXAMETHASONE; DOPAMINE; OXYGEN; SURFACTANT;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; EARLY DIAGNOSIS; EYE FUNDUS; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MATURITY; MOTHER; OXYGEN THERAPY; PATIENT SELECTION; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PREMATURITY; PREVALENCE; QUANTITATIVE ANALYSIS; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; SCREENING TEST; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VISUAL SYSTEM EXAMINATION;

APGAR SCORE; CHINA; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEONATAL SCREENING; OXYGEN INHALATION THERAPY; PREVALENCE; RETINOPATHY OF PREMATURITY; RISK FACTORS;

EID: 33749866073     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fielder AR, Reynolds JD. Retinopathy of prematurity: clinical aspects. Semin Neonatol, 2001, 6(6):461-475.
2. Autrata R, Holousova M, Rehurek J. Cryotherapy and photocoagulation in the treatment of retinopathy of prematurity. Cesk Slov Oftalmol, 2002, 58(1):30-35.
3. Hartnett ME. Feathers associated with surgical outcome in patients with stage 4 and 5 retinopathy of prematurity. Retina, 2003, 23(3):322-329.
4. Gergelyova K, Odehnal M. Pars plana vitrectomy in retinopathy of prematurity. Cesk Slov Oftalmol, 2001, 57(6):387-394.
5. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol, 1984, 102(8):1130-1134.
6. Reynolds JD, Dobson V, Quinn GE, et al. Evidence-based screening criterial for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol, 2002, 120(11):1470-1476.
7. Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity: Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med, 1998, 338(22):1572-1576.
8. Palmer E, Flynn J, Hardy R, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology, 1991, 98(11): 1628-1640.
9. Daniel EN, Lisa B, Evelyn A, et al. Association of candidemia and retinopathy of prematurity in very low birth weighy infants. Ophthalmology, 2002, 109(1):80-84.
10. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial: I. Primary outcomes. Pediatrics, 2000, 105(2):295-310.
11. Simons B, Flynn J. Retinopathy of prematurity and associated factors. Int Ophthalmol Clin, 1999, 39(2):29-48.